telehealth

Telehealth darling Hims & Hers Health Inc (NYSE:HIMS) got slapped with a 34% stock crash on Monday. Novo Nordisk A/S (NYSE:NVO) ended their relationship – and it wasn't amicable. But is the plunge a chance to swipe right on the dip, or should investors ghost the stock altogether? The high...

Hims & Hers Health, Inc. (NYSE:HIMS) reported its second-quarter financial results Monday. Here's a look at the details from the report.  The Details: Hims & Hers Health reported quarterly earnings of 6 cents per share which beat the analyst consensus estimate of 3 cents. Quarterly sales...

Telehealth company Teladoc Health Inc (NYSE:TDOC) reported second-quarter financial results after market close Wednesday. Here are the key highlights. What Happened: Teladoc reported second-quarter revenue of $642.4 million, down 2% year-over-year. The revenue total missed a Street consensus...

Alphabet Inc’s (NASDAQ:GOOG) (NASDAQ:GOOGL) Google and TikTok have banned Done Global from advertising on their platforms amid a widening federal crackdown on the telehealth company’s distribution of Adderall and other stimulants. Adderall is the most commonly used to treat...

Big box retailer Costco Wholesale Corporation (NASDAQ: COST) is best known for its oversized items that allow customers to load up in bulk on food and household items. The company also offers its share of extra items like televisions, insurance plans, auto services, and a $1.50 hot dog and drink...

Orphan and rare diseases drug company Lobe Sciences Ltd. (OTCQB: LOBEF) is set to acquire Altemia & Company LLC. The deal includes all Altemnia assets, intellectual property, and commercial inventory to manage patients suffering from Sickle Cell Disease (SCD), a group of hereditary red blood...

Research and telemedicine company Braxia Scientific Corp. (OTC: BRAXF) has filed its financial statements for the third quarter ended Dec. 31, 2022, and shared an update on its proposed acquisition by Irwin Naturals (OTCQB: IWINF). Financial results for the period show: Total revenue of $359...

This article was originally published on Microdose and appears here with permission. Ketamine telehealth is a bit of an enigma — an off-label drug combined with at-home treatment, allowed because of originally temporary Public Health Emergency legislation put in place for...

Psychedelics mental wellness telehealth company Nue Life Health PBC is now offering Nue Care, a personalized six-month aftercare program to treat the root causes of mental health disorders with personal sessions, progress tracking, health coaching, integration support and supplements towards...

Virtual healthcare provider Teladoc Health (NYSE: TDOC) has been a favorite stock pick of Cathie Wood, CEO of Ark Invest. After shares dropped 18% on Thursday from second quarter financial results, Wood defended the pick and bought the dip. What Happened: Shares of Teladoc Health fell Thursday...

Cathie Wood-led Ark Investment Management on Thursday bought the dip in shares of telehealth services provider Teladoc Health, Inc. (NYSE: TDOC). Teladoc is a component in Ark’s four ETFs, namely its flagship ARK Innovation ETF (NYSE: ARKK), the ...

Is At-Home Ketamine Treatment Safe For Patients? A new clinical study of sublingual ketamine telehealth is adding data to the notion that at-home ketamine treatments can be safe and effective for moderate to severe cases of anxiety and depression.  The study was conducted by psychiatrists...

On July 10, Bank of America Corp (NYSE: BAC) analyst Allen Lutz published an analyst note on Teladoc Health, Inc (NYSE: TDOC). What Happened: The Bank of America analyst had a Neutral rating on Teladoc with a $42 price objective. Lutz’s analysis came after the company...

Canadian healthcare company Ask The Doctor has added $1.5 million worth of Shiba Inu (CRYPTO: SHIB) to its balance sheet. What Happened: In an announcement on Wednesday, the Toronto-based telehealth service said it had acquired 31 billion Shiba Inu tokens worth approximately $1.5 million, at the...

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, has finalized a contract with PeopleOne Health to be the...